Volume 385, Issue 9970
28 February 2015
As the new Deputy Commissioner for Medical Products and Tobacco at the US Food and Drug Administration (FDA), world-renowned cardiologist Robert Califf arrives at a time when the FDA’s overall responsibilities have grown exponentially. The Lancet‘s Washington correspondent, Susan Jaffe, reports. [article continued as full text or PDF] [Podcast with Dr. Califf here.]
(Visited 5 times, 1 visits today)